BioTrinity
1 April 20252 April 2025
London, UKConvene 133 Houndsditch
BioTrinity, now in its 19th year, is OBN's flagship two-day conference for the life sciences industry, designed to catalyse growth for all who attend.
The two-day conference programme for 2025 features a dual track of showcase presentations from R&D companies at around the Series A stage, across 14 different therapy areas, a packed business & investment track, sponsors exhibition, networking events, private partnering meetings and an academic poster presentation.
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze